Evidence map›Paper›PMID 23841577›Full record

ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2013

Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.

JoonHo Lee, Roberto Romero, Yi Xu, Jezid Miranda, Wonsuk Yoo, Piya Chaemsaithong, Juan Pedro Kusanovic, Tinnakorn Chaiworapongsa, Adi L Tarca, Steven J Korzeniewski and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth.medRxiv : the preprint server for health sciences · 2025
    Article
  7. Article
  8. Proteomic Profiles of Maternal Plasma Extracellular Vesicles for Prediction of Preeclampsia.American journal of reproductive immunology (New York, N.Y. : 1989) · 2024
    Article
  9. Review
  10. Immunologic aspects of preeclampsia.AJOG global reports · 2024
    Review
  11. Article
  12. Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Review
  13. Memory B Cells in Pregnancy Sensitization.Frontiers in immunology · 2021
    Review
  14. Article
  15. Article
  16. HLA antibody repertoire in infants suggests selectivity in transplacental crossing.American journal of reproductive immunology (New York, N.Y. : 1989) · 2020
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

JoonHo LeePerinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, USA.
Roberto Romero
Yi Xu
Jezid Miranda
Wonsuk Yoo
Piya Chaemsaithong
Juan Pedro Kusanovic
Tinnakorn Chaiworapongsa
Adi L Tarca
Steven J Korzeniewski
Sonia S Hassan
Nandor Gabor Than
Bo Hyun Yoon
Chong Jai Kim
United States Department of Health and Human Services · USWayne State University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USSeoul National University · KRUniversity of Tennessee Health Science Center · US

Funding

The Role Of Subclinical Infection And Cytokines In Preterm ParturitionZIAHD002400 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI ROMERO, ROBERTO · 2009 to 2025
$254.4M
Intramural NIH HHS ZIA HD002400NICHD NIH HHS HHSN275201300006C
6 · The paper itself

Abstract

problemMaternal anti-fetal rejection is a mechanism of disease in spontaneous preterm labor. The objective of this study was to determine whether the presence of human leukocyte antigen (HLA) panel-reactive antibodies (PRA) during the second trimester increases the risk of spontaneous preterm delivery. METHODS OF STUDY: This longitudinal case-control study included pregnant women with spontaneous preterm deliveries (n = 310) and control patients with normal term pregnancies (n = 620), matched for maternal age and gravidity. Maternal plasma samples obtained at 14-16, 16-20, 20-24, and 24-28 weeks of gestation were analyzed for HLA class I and class II PRA positivity using flow cytometry. The fetal HLA genotype and maternal HLA alloantibody epitope were determined for a subset of patients with positive HLA PRA.

results(i) Patients with spontaneous preterm delivery were more likely to exhibit HLA class I (adjusted OR = 2.54, P < 0.0001) and class II (adjusted OR = 1.98, P = 0.002) PRA positivity than those delivering at term; (ii) HLA class I PRA positivity for patients with spontaneous preterm delivery between 28 and 34 weeks (adjusted OR = 2.88; P = 0.001) and after 34 weeks of gestation (adjusted OR = 2.53; P < 0.0001) was higher than for those delivering at term; (iii) HLA class II PRA positivity for patients with spontaneous preterm delivery after 34 weeks of gestation was higher than for those delivering at term (adjusted OR = 2.04; P = 0.002); (iv) multiparous women were at a higher risk for HLA class I PRA positivity than nulliparous women (adjusted OR = 0.097, P < 0.0001 for nulliparity); (v) nulliparous women had a higher rate of HLA class I PRA positivity with advancing gestational age (P = 0.001); and (vi) 78% of women whose fetuses were genotyped had alloantibodies specific against fetal HLA class I antigens.

conclusionPregnant women with positive HLA class I or class II PRA during the second trimester are at an increased risk of spontaneous preterm delivery due to antibody-mediated maternal anti-fetal rejection.

Indexed as

AdolescentAdultAntibodiesCase-Control StudiesFemaleFetusHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensHumansInfant, NewbornIsoantibodiesMiddle AgedPregnancyPregnancy Trimester, SecondPremature BirthAntibodiesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensIsoantibodiesFlow cytometrypreterm birthrejectiontransplantation

Identifiers

PMID23841577
PMCPMC4154511
OpenAlexW1989206432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.